SPTX Stock: Price, Earnings History and SEC Filings
Seaport Therapeutics, Inc. (SPTX) last traded at $19.60, down 7.11% on the latest session and down 2.8% over the past month. In its most recent reported quarter (Jun 2026) earnings per share were $-1.78 against an analyst estimate of $-0.71, a miss of 150.7%.
Price data from Yahoo Finance, as of Oct 30, 2026. May be delayed.
SPTX earnings history
| Quarter | Reported | EPS | Estimate | Surprise |
|---|---|---|---|---|
| Jun 2026 | Aug 3, 2026 | $-1.78 | $-0.71 | -150.70% |
| Mar 2026 | Jun 8, 2026 | $-10.34 | $-10.64 | +2.82% |
SPTX beat the analyst EPS estimate in 1 of its last 2 reported quarters. Source: Nasdaq.
Latest SEC filings for SPTX
Insider filing activity
SPTX insiders filed 0 Form 4 reports in the last 90 days. A Form 4 is how directors and executives disclose purchases, sales and grants of company stock. See the individual filings on SEC EDGAR. Many Form 4 filings are routine, such as scheduled sales or option exercises, so check each filing before drawing a conclusion.
Source: SEC EDGAR.
SPTX news
- Seaport Therapeutics to Present at Stifel 2026 Healthcare ConferenceOct 28, 2026 · finance.yahoo.com
- Is Seaport Therapeutics (SPTX) Overvalued Based On Book Value?Oct 25, 2026 · finance.yahoo.com
- Seaport Therapeutics (SPTX) Looks Cheap After Its Cash Runway Narrative Took Center StageOct 25, 2026 · finance.yahoo.com
About Seaport Therapeutics, Inc.
Seaport Therapeutics, Inc. (SPTX) is a US-listed public company on Nasdaq. The SEC classifies its business as Pharmaceutical Preparations. It is incorporated in DE. Its fiscal year ends in December.